Φορτώνει......
Evolving Antibody Therapies for the Treatment of Type 1 Diabetes
Type 1 diabetes (T1D) is widely considered to be a T cell driven autoimmune disease resulting in reduced insulin production due to dysfunction/destruction of pancreatic β cells. Currently, there continues to be a need for immunotherapies that selectively reestablish persistent β cell-specific self-t...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Front Immunol |
|---|---|
| Κύριοι συγγραφείς: | , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Frontiers Media S.A.
2021
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7930374/ https://ncbi.nlm.nih.gov/pubmed/33679717 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.624568 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|